Cargando…

Model-Based Integration Analysis Revealed Presence of Novel Prognostic miRNA Targets and Important Cancer Driver Genes in Triple-Negative Breast Cancers

Background: miRNAs (microRNAs) play a key role in triple-negative breast cancer (TNBC) progression, and its heterogeneity at the expression, pathological and clinical levels. Stratification of breast cancer subtypes on the basis of genomics and transcriptomics profiling, along with the known biomark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaka, Masood, Sutton, Chris W., Peng, Yonghong, Konur, Savas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139587/ https://www.ncbi.nlm.nih.gov/pubmed/32182819 http://dx.doi.org/10.3390/cancers12030632

Ejemplares similares

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
por: Huang, Yuan, et al.
Publicado: (2021)

A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer
por: Turkistani, Safaa, et al.
Publicado: (2021)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
por: Mathe, Andrea, et al.
Publicado: (2015)

Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
por: Shin, V Y, et al.
Publicado: (2015)

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
por: Ferreira, Lívia C., et al.
Publicado: (2020)

Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
por: Andrade, Fernando, et al.
Publicado: (2020)

The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
por: Adinew, Getinet M., et al.
Publicado: (2021)

Response to: Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'
por: Shin, Vivian Y, et al.
Publicado: (2016)

MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis
por: Liu, Yanli, et al.
Publicado: (2017)

MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology
por: Shu, Dan, et al.
Publicado: (2015)

Integrated analysis of the potential roles of miRNA-mRNA networks in triple negative breast cancer
por: Zhu, Huiru, et al.
Publicado: (2017)

The Role of miRNAs in the Prognosis of Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
por: Santana, Talita Araújo B. da S., et al.
Publicado: (2022)

Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients
por: Almohaywi, Maram, et al.
Publicado: (2023)

A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
por: Kwon, Jeanny, et al.
Publicado: (2017)

S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a
por: Coppola, Alessandra, et al.
Publicado: (2020)

Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers
por: Valcourt, Danielle M., et al.
Publicado: (2020)

Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2017)

Circulating miRNAs in HER2-Positive and Triple Negative Breast Cancers: Potential Biomarkers and Therapeutic Targets
por: Gupta, Ishita, et al.
Publicado: (2020)

Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake
por: Li, Zhen, et al.
Publicado: (2019)

Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients
por: Sugita, Bruna M., et al.
Publicado: (2019)

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer
por: Gorur, Aysegul, et al.
Publicado: (2021)

Identification of Exo-miRNAs: A Summary of the Efforts in Translational Studies Involving Triple-Negative Breast Cancer
por: Encarnación-Medina, Jarline, et al.
Publicado: (2023)

Expression of Concern: MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis
Publicado: (2023)

MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
por: Shi, Zhendong, et al.
Publicado: (2017)

Verifiable biology
por: Konur, Savas, et al.
Publicado: (2023)

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
por: Tormo, Eduardo, et al.
Publicado: (2019)

Chromosome 19 miRNA cluster and CEBPB expression specifically mark and potentially drive triple negative breast cancers
por: Jinesh, Goodwin G., et al.
Publicado: (2018)

Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women
por: Sugita, Bruna, et al.
Publicado: (2016)

Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
por: Thakur, Seema, et al.
Publicado: (2016)

Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease
por: Qattan, Amal
Publicado: (2020)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
por: Zeindler, Jasmin, et al.
Publicado: (2019)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
por: Zurlo, Giada, et al.
Publicado: (2019)

Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells
por: Ku, Geng Chia, et al.
Publicado: (2022)

Novel Ground-Up 3D Multicellular Simulators for Synthetic Biology CAD Integrating Stochastic Gillespie Simulations Benchmarked with Topologically Variable SBML Models
por: Matzko, Richard Oliver, et al.
Publicado: (2023)

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs
por: Riaz, Muhammad, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1dt3fmq65ctiip0t4bvmc7p9g8